TWI BIOTECHNOLOGY INCTWI BIOTECHNOLOGY INCTWI BIOTECHNOLOGY INC

TWI BIOTECHNOLOGY INC

No trades
See on Supercharts

6610 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

TWi Biotechnology, Inc. operates as a clinical stage biopharmaceutical company. It engages in the research and development of repositioned drugs for unmet medical needs, especially in rare diseases associated with innate immunity. The company was founded by Chih Ming Chen on July 16, 2010 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
6610 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company